medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2009, Number S1

<< Back Next >>

Ann Hepatol 2009; 8 (S1)

Association between type two diabetes and non-alcoholic fatty liver disease in youth

Alisi A, Manco M, Panera N, Nobili V

Language: English
References: 90
Page: 44-50
PDF size: 82.70 Kb.


Text Extraction

In the last three decades prevalence of insulin related diseases has been growing worldwide with epidemic obesity, type 2 diabetes mellitus and non alcoholic fatty liver disease. In children such epidemics are particularly worrisome, since metabolic abnormalities track to the adulthood with significant implications for the health care system. Epidemiological studies support a close association between type 2 diabetes and fatty liver disease. We review the most recent epidemiological data on prevalence of both diseases in youth and their association.


REFERENCES

  1. Shaw J. Epidemiology of childhood type 2 diabetes and obesity. Pediatr Diabetes 2007; 8 (Suppl 9): 7-15.

  2. De Ferranti SD, Osganian SK. Epidemiology of paediatric metabolic syndrome and type 2 diabetes mellitus. Diab Vasc Dis Res 2007; 4: 285-96.

  3. Matyka KA. Type 2 diabetes in childhood: epidemiological and clinical aspects. Br Med Bull 2008; 86: 59-75.

  4. Eckel RE. Insulin resistance; an adaptation for weight maintenance. Lancet 1992; 340: 1542-3.

  5. Burcelin R, Knauf C, Cani PD. Pancreatic alpha-cell dysfunction in diabetes. Diabetes Metab 2008; 34 (Suppl 2): S49-55.

  6. Morrison JA, Ford ES, Steinberger J. The pediatric metabolic syndrome. Minerva Med 2008; 99: 269-87.

  7. Newfield RS, Dewan AK, Jain S. Dyslipidemia in children with type 2 diabetes vs. obesity. Pediatr Diabetes 2008; 9: 115-21.

  8. Franks S. Polycystic ovary syndrome in adolescents. Int J Obes (Lond) 2008; 32: 1035-41.

  9. Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30: 1212-8.

  10. Preiss D, Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond) 2008; 115: 141-50.

  11. Yeh MM, Brunt EM. Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol 2007; 128: 837-47.

  12. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43 (2 Suppl 1): S99-S112.

  13. Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2008; 28: 13-24.

  14. Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond) 2008; 32: 381-7.

  15. Manco M, Bedogni G, Marcellini M, Devito R, Ciampalini P, Sartorelli MR, Comparcola D, et al. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. Gut 2008; 57: 1283-7.

  16. Jones TF. Type 2 diabetes in children: a growing epidemic. Ky Nurse 2007; 55: 7-8.

  17. American Diabetes Association. Type 2 diabetes in children and adolescents (Consensus Statement). Diabetes Care 2000; 23: 381-389.

  18. Alberti G, Zimmet P, Shaw J, Bloomgarden Z, Kaufman F, Silink M. Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care 2004; 27: 1798-811.

  19. Cali AM, Caprio S. Prediabetes and type 2 diabetes in youth: an emerging epidemic disease? Curr Opin Endocrinol Diabetes Obes 2008; 15: 123-7.

  20. SEARCH for Diabetes in Youth Study Group, Liese AD, D’Agostino RB Jr, Hamman RF, Kilgo PD, Lawrence JM, Liu LL, Loots B et al. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics 2006;118:1510-8.

  21. Duncan GE. Prevalence of diabetes and impaired fasting glucose levels among US adolescents: National Health and Nutrition Examination Survey, 1999-2002. Arch Pediatr Adolesc Med 2006; 160: 523-8.

  22. Haines L, Wan KC, Lynn R, Barrett TG, Shield JP. Rising incidence of type 2 diabetes in children in the U.K. Diabetes Care 2007; 30: 1097-101.

  23. Writing Group for the SEARCH for Diabetes in Youth Study Group, Dabelea D, Bell RA, D’Agostino RB Jr, Imperatore G, Johansen JM, Linder B, Liu LL, et al. Incidence of diabetes in youth in the United States. JAMA 2007; 27:2716-24. Erratum in: JAMA 2007 8; 298: 627.

  24. Campbell-Stokes PL, Taylor BJ. New Zealand Children’s Diabetes Working Group. Prospective incidence study of diabetes mellitus in New Zealand children aged 0 to 14 years. Diabetologia 2005; 48: 2442-3.

  25. Li Y, Yang X, Zhai F, Piao J, Zhao W, Zhang J, Ma G. Childhood obesity and its health consequence in China. Obes Rev 2008; 9 (Suppl 1): 82-6.

  26. Mazza CS, Ozuna B, Krochik AG, Araujo MB. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in obese Argentinean children and adolescents. J Pediatr Endocrinol Metab 2005; 18: 491-8.

  27. Holst-Schumacher I, Nuñez-Rivas H, Monge-Rojas R, Barrantes-Santamaría M. Insulin resistance and impaired glucose tolerance in overweight and obese Costa Rican schoolchildren. Food Nutr Bull 2008; 29: 123-31.

  28. Wabitsch M, Hauner H, Hertrampf M, Muche R, Hay B, Mayer H, Kratzer W, et al. Type II diabetes mellitus and impaired glucose regulation in Caucasian children and adolescents with obesity living in Germany. Int J Obes Relat Metab Disord 2004; 28: 307-13.

  29. Wiegand S, Dannemann A, Krude H, Grüters A. Impaired glucose tolerance and type 2 diabetes mellitus: a new field for pediatrics in Europe. Int J Obes (Lond) 2005; 29 (Suppl 2): S136-42.

  30. Herder C, Schmitz-Beuting C, Rathmann W, Haastert B, Schmitz-Beuting J, Schäfer M, Scherbaum WA, et al. Prevalence of impaired glucose regulation in German school-leaving students. Int J Obes (Lond) 2007; 3: 1086-8.

  31. Felszeghy E, Juhasz E, Kaposzta R, Ilyes I. Alterations of glucoregulation in childhood obesity—association with insulin resistance and hyperinsulinemia. J Pediatr Endocrinol Metab 2008; 2: 847-53.

  32. Shalitin S, Abrahami M, Lilos P, Phillip M. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel. Int J Obes (Lond) 2005; 2: 571-8.

  33. Invitti C, Gilardini L, Pontiggia B, Morabito F, Mazzilli G, Viberti G. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy. Nutr Metab Cardiovasc Dis 2006; 16: 256-62.

  34. Babaoğlu K, Hatun S, Arslanoğlu I, Işgüven P, Baş F, Ercan O, Darendeliler F, et al. Evaluation of glucose intolerance in adolescents relative to adults with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2006; 19: 1319-26.

  35. Atabek ME, Pirgon O, Kurtoglu S. Assessment of abnormal glucose homeostasis and insulin resistance in Turkish obese children and adolescents. Diabetes Obes Metab 2007; 9: 304-10.

  36. Atabek ME, Pirgon O, Kurtoglu S. Prevalence of metabolic syndrome in obese Turkish children and adolescents. Diabetes Res Clin Pract 2006; 72: 315-21.

  37. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2007; 25: 883-9.

  38. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-50.

  39. Dunn W, Schwimmer JB. The obesity epidemic and nonalcoholic fatty liver disease in children. Curr Gastroenterol Rep 2008; 10: 67-72.

  40. Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK, Chan IH, et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 2004; 28: 1257-63.

  41. Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci MP, Saviano MC, Brunetti F, et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997; 42: 1428-32.

  42. Yoo J, Lee S, Kim K, Yoo S, Sung E, Yim J. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children. Diabetes Res Clin Pract 2008; 81: 321-6.

  43. Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 2005; 115: e561-5.

  44. Louthan MV, Theriot JA, Zimmerman E, Stutts JT, McClain CJ. Decreased prevalence of nonalcoholic fatty liver disease in black obese children. J Pediatr Gastroenderol Nutr 2005; 41: 426-9.

  45. Kinugasa A, Tsunamoto K, Furukawa N, Sawada T, Kusunoki T, Shimida N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr 1984; 3: 408–14.

  46. Kawasaki T, Hashimoto N, Kikuchi T, Takahashi H, Uchiyama M. The relationship between fatty liver and hyperinsulinemia in obese Japanese children. J Pediatr Gastroenterol Nutr 1997; 24: 317-21.

  47. Tazawa Y, Noguchi H, Nishinomiya F, Takada G. Serum alanine aminotransferases activity in obese children. Acta Paediatr 1997; 86: 238-41.

  48. Zou CC, Liang L, Hong F, Fu JF, Zhao ZY. Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children. Endocr J 2005; 52: 519-24.

  49. Schwimmer BJ, Deutsch R, Kahen T, Lavine EJ, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118: 1388-93.

  50. Papandreou D, Rousso I, Mavromichalis I. Update on non-alcoholic fatty liver disease in children. Clin Nutr 2007; 26: 409.

  51. Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr 2006; 43: 413.

  52. Manco M, Alisi A, Nobili V. Risk of severe liver disease in NAFLD with normal ALT levels. A pediatric report. Hepatology 2008; in press.

  53. Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr 2000; 136: 727-33.

  54. Park HS, Han JH, Choi KM, Kim SM. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr 2005; 82: 1046-51.

  55. Flores-Calderon J, Gomez-Diaz RA, Rodriguez-Gomez G, Moran-Villota S. Frequency of increased aminotransferases levels and associated metabolic abnormalities in obese and overweight children of an elementary school in Mexico City. Ann Hepatol 2005; 4: 279-83.

  56. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, Kusano Y. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995; 40: 2002-9.

  57. Guzzaloni G, Grugni G, Minocci A, Moro D, Morabito F. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord 2000; 24: 772-6.

  58. Sartorio A, Del Col A, Agosti F, Mazzilli G, Bellentani S, Tiribelli C, Bedogni G. Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr 2007; 61: 877-83.

  59. Fu JF, Liang L, Wang CL, Hong F, Dong GP, Li Y. Nonalcoholic steatohepatitis in obese children: the prevalence and possible mechanism. Zhejiang Da Xue Xue Bao Yi Xue Ban 2006; 35: 64-8.

  60. Tuba F. Eminoğlu1, Orhun M. Çamurdan2, Suna Ö. Oktar3, Aysun Bideci2, Buket DalgiÇ4 Factors related to non-alcoholic fatty liver disease in obese children. The Turkish Journal of Gastroenterology 2008; 19: 85-91.

  61. Bergomi A, Lughetti L, Corciulo N. Italian multicenter study on liver damage in pediatric obesity. Int J Obes Relat Metab Disord 1998; 22: S22.

  62. Weiss R, Caprio S. Development of type 2 diabetes in children and adolescents. Minerva Med 2006; 97: 263-9.

  63. Pattaranit R, van den Berg HA, Spanswick D. The development of insulin resistance in Type 2 diabetes: insights from knockout studies. Sci Prog 2008; 91: 285-316.

  64. Schmitz-Peiffer C, Biden TJ. Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes. Diabetes 2008; 57: 1774-83.

  65. White MF. IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 2002; 283: E413-22.

  66. Weiss R, Gillis D. Patho-physiology and dynamics of altered glucose metabolism in obese children and adolescents. Int J Pediatr Obes 2008; 3 (Suppl 1): 15-20.

  67. Berry D, Urban A, Grey M. Understanding the development and prevention of type 2 diabetes in youth (part 1). J Pediatr Health Care 2006; 20: 3-10.

  68. Silverstein JH, Rosenbloom AL. Type 2 diabetes in children. Urr Diab Rep 2001; 1: 19-27.

  69. Gill-Carey O, Hattersley AT. Genetics and type 2 diabetes in youth. Pediatr Diabetes 2007; 8 (Suppl 9): 42-7.

  70. Pavkov ME, Hanson RL, Knowler WC, Bennett PH, Krakoff J, Nelson RG. Changing patterns of type 2 diabetes incidence among Pima Indians. Diabetes Care 2007; 30: 1758-63.

  71. Sugihara S, Sasaki N, Amemiya S, Kohno H, Tanaka T, Matsuura N. Analysis of weight at birth and at diagnosis of childhood-onset type 2 diabetes mellitus in Japan. Pediatr Diabetes 2008; 8(9): 285-90.

  72. Jasik CB, Lustig RH. Adolescent obesity and puberty: the «perfect storm». Ann N Y Acad Sci 2008; 1135: 265-79.

  73. Day CP, James OFW. Steatohepatitis: A tale of two «hits»? Gastroenterology 1998; 14: 842-5.

  74. Day CP. NASH-related liver failure: one hit too many? Am J Gastroenterol 2002; 7: 1872-4.

  75. Charlton M. Noninvasive indices of fibrosis in NAFLD: starting to think about a three hit (at least) phenomenon. Am J Gastroenterol 2007; 102: 409-11.

  76. Day CP. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int 2006; 26: 1021-28.

  77. Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med 2008; 14: 72-81.

  78. Saito T, Misawa K, Kawata S. Fatty liver and non-alcoholic steatohepatitis. Intern Med 2007; 46: 101-13.

  79. Ahima RS. Insulin resistance: cause or consequence of nonalcoholic steatohepatitis? Gastroenterology 2007; 132: 444-6.

  80. Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology 2002; 35: 898-904.

  81. Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006; 6: 1-28

  82. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-92.

  83. Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006; 6: 1-28.

  84. Feldstein AE, Werneburg NW, Canbay A, Guicciardi ME, Bronk SF, Rydzewski R, Burgart LJ, et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 2004; 40: 185-94.

  85. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 2004; 40: 46-5.

  86. Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol 2008; 49: 608-12.

  87. Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 2006; 22: 437-43.

  88. Sattar N, Scherbakova O, Ford I, O’Reilly DS, Stanley A, Forrest E, Macfarlane PW, et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes 2004; 53: 2855-60.

  89. Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 2005; 28: 2913-8.

  90. Schwimmer JR, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003; 143: 500-5.




2020     |     www.medigraphic.com